CVE-2024-41668

HIGH
Published Jul 23, 2024 Modified Apr 15, 2026 CWE-918

Description

The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.

Is your site exposed to CVE-2024-41668?

Run a free security scan — no signup, results in seconds.

CVSS v3.1 Score

8.3
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L

Weakness Type (CWE)

CWE-918 Server-Side Request Forgery (SSRF)

References

Frequently Asked Questions

What is CVE-2024-41668? +
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx. It has a CVSS v3.1 base score of 8.3 (HIGH).
How severe is CVE-2024-41668? +
CVE-2024-41668 has a CVSS v3.1 score of 8.3 out of 10, rated HIGH. This is a high-severity vulnerability that should be prioritized for patching.
How do I check if I'm vulnerable to CVE-2024-41668? +
You can use Secably's free Website Scanner to check your website for known vulnerabilities. For infrastructure scanning, use the Port Scanner to identify exposed services that may be affected. Check the vendor advisories linked above for specific patch and version information.

Related Vulnerabilities

Don't wait for an exploit

Scan your website for vulnerabilities like CVE-2024-41668 — free, no signup required.